The workshop seeks to identify, discuss, and address key issues, challenges and opportunities faced by industry, regulatory, and academic partners – along with the concerns and interests of patients and patient advocates – in the pursuit of neoadjuvant therapies for surgically resectable melanoma.

The workshop will convene stakeholders from across the melanoma research continuum – including academia, researchers, clinicians of various expertise, patient groups, industry, and FDA – to further explore opportunities and discuss challenges in the development of neoadjuvant therapies for melanoma. 

Register by Nov. 4th.